×
Back to Agenda
Multi-stakeholder considerations for sustainable clinical trials – why is it important and what action is needed?
Session Chair(s)
Dan Reed, PHD
Senior Regulatory Intelligence Director, AstraZeneca, United Kingdom
Claudia Percivalle, PHD, MSC
Regulatory Affairs Director , AstraZeneca, United Kingdom
Multi-stakeholder considerations for sustainable clinical trials – why is it important and what action is needed?
Have an account?